Epigenetic Regulation of Autophagy in Breast Cancer: Implications for Biomarker Discovery and Personalized Therapy

Area of Science:

• Oncology
• Epigenetics
• Molecular Biology

Background:

• Breast cancer is a leading cause of death in women, with therapeutic resistance limiting treatment efficacy.
• Epigenetic dysregulation and autophagy are increasingly recognized as critical factors in breast cancer progression and resistance.
• The interplay between epigenetic modifications (histone modifications, non-coding RNAs, DNA methylation) and autophagy regulates genes involved in cancer cell fate and drug sensitivity.

Purpose of the Study:

• To review recent research on how epigenetic mechanisms influence autophagy in breast cancer.
• To explore the role of the epigenetic-autophagy axis in mediating resistance to various cancer therapies.
• To highlight the potential of epigenetic-autophagy interactions as biomarkers for early detection and treatment response prediction.

Main Methods:

• Literature review of recent studies on epigenetic regulation of autophagy in breast cancer.
• Analysis of the impact of epigenetic-autophagy crosstalk on therapeutic resistance pathways.
• Exploration of emerging biomarkers and therapeutic strategies targeting this interplay.

Main Results:

• Epigenetic modifications dynamically regulate autophagy-related genes, influencing breast cancer cell survival and drug response.
• Autophagy, in turn, can modulate the epigenetic landscape, particularly under stress conditions like chemotherapy.
• This bidirectional crosstalk is a significant determinant of sensitivity to chemotherapy, endocrine therapy, and targeted agents.

Conclusions:

• Targeting the epigenetic-autophagy crosstalk presents a promising strategy to overcome therapeutic resistance in breast cancer.
• Combination therapies involving epigenetic modulators and autophagy inhibitors show potential for improved patient outcomes.
• AI-driven drug discovery and precision oncology approaches can accelerate the development of novel treatments for this complex interplay.